Orally administered liposomal lactoferrin inhibits inflammation-related bone breakdown without interrupting orthodontic tooth movement

Journal of Periodontology

Volumn 84, Issue 10, 2013, Pages 1454-1462

  Kawazoe, A ^a   Inubushi, T ^a   Miyauchi, M ^a   Ishikado, A ^b   Tanaka, E ^c   Tanne, K ^a   Takata, T ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Sunstar Inc   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cytokines; Inflammation; Orthodontics; Osteoclasts; Periodontal diseases; Tooth movement

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANTIINFECTIVE AGENT; ISOENZYME; LACTOFERRIN; LIPOPOLYSACCHARIDE; LIPOSOME; OSTEOCLAST DIFFERENTIATION FACTOR; TARTRATE-RESISTANT ACID PHOSPHATASE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BONE REMODELING; CATTLE; CELL COUNT; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ESCHERICHIA COLI; JAW; MALE; MECHANICAL STRESS; METHODOLOGY; ORAL DRUG ADMINISTRATION; OSTEOCLAST; PATHOLOGY; PERIODONTAL DISEASE; PERIODONTITIS; PERIODONTIUM; PILOT STUDY; RANDOMIZATION; RAT; TOOTH CERVIX; WISTAR RAT;

ACID PHOSPHATASE; ADMINISTRATION, ORAL; ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; ANTI-INFECTIVE AGENTS; BONE REMODELING; CATTLE; CELL COUNT; EPITHELIAL ATTACHMENT; ESCHERICHIA COLI; ISOENZYMES; LACTOFERRIN; LIPOPOLYSACCHARIDES; LIPOSOMES; MALE; OSTEOCLASTS; PERIODONTITIS; PILOT PROJECTS; RANDOM ALLOCATION; RANK LIGAND; RATS; RATS, WISTAR; STRESS, MECHANICAL; TOOTH CERVIX; TOOTH MOVEMENT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884881422     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120508     Document Type: Article

References (31)

1. Wennström JL, Stokland BL, Nyman S, Thilander B. Periodontal tissue response to orthodontic movement of teeth with infrabony pockets. Am J Orthod Dentofacial Orthop 1993;103:313-319.
2. Boyd RL, Chun YS. Eighteen-month evaluation of the effects of a 0.4% stannous fluoride gel on gingivitis in orthodontic patients. Am J Orthod Dentofacial Orthop 1994;105:35-41.
3. Murray DA, Wilton JM. Lipopolysaccharide from the periodontal pathogen Porphyromonas gingivalis prevents apoptosis of HL60-derived neutrophils in vitro. Infect Immun 2003;71:7232-7235. (Pubitemid 37475365)
4. Tomomatsu N, Aoki K, Alles N, et al. LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model. J Bone Miner Res 2009;24:1770-1781.
5. Conneely OM. Antiinflammatory activities of lactoferrin. J Am Coll Nutr 2001;20(Suppl. 5):389S-395S.
6. Lönnerdal B, Iyer S. Lactoferrin: Molecular structure and biological function. Annu Rev Nutr 1995;15:93-110.
7. Wakabayashi H, Yamauchi K, Takase M. Lactoferrin research, technology and applications. Int Dairy J 2006;16:1241-1251. (Pubitemid 44331588)
8. Guillen C, McInnes IB, Vaughan D, Speekenbrink AB, Brock JH. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum 2000;43:2073-2080.
9. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta 1992; 1121:130-136.
10. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. Antiviral activities of lactoferrin. Antiviral Res 2001;52:225-239. (Pubitemid 33000113)
11. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994;54:2310-2312. (Pubitemid 24138715)
12. Yamauchi K, Wakabayashi H, Hashimoto S, Teraguchi S, Hayasawa H, Tomita M. Effects of orally administered bovine lactoferrin on the immune system of healthy volunteers. Adv Exp Med Biol 1998;443:261-265. (Pubitemid 28432195)
13. Haversen L, Ohlsson BG, Hahn-Zoric M, Hanson LA, Mattsby-Baltzer I. Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol 2002;220: 83-95. (Pubitemid 36349060)
14. Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J Vet Med Sci 2004;66: 149-154. (Pubitemid 41380329)
15. Yamano E, Miyauchi M, Furusyo H, et al. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. Lab Invest 2010;90:1236-1246.
16. Inubushi T, Kawazoe A, Miyauchi M, et al. Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 2012;287:23527-23536.
17. Ishikado A, Uesaki S, Suido H, et al. Human trial of liposomal lactoferrin supplementation for periodontal disease. Biol Pharm Bull 2010;33:1758-1762.
18. Minkin C, Yu XH. Calcitonin receptor expression and its regulation by 1 alpha-25-dihydroxyvitamin D3 during de novo osteoclast formation in organ cultures of fetal mouse metatarsals. Bone Miner 1991;13: 191-200.
19. Ren Y, Maltha JC, Van 't Hof MA, Kuijpers-Jagtman AM. Optimum force magnitude for orthodontic tooth movement: A mathematic model. Am J Orthod Dentofacial Orthop 2004;125:71-77. (Pubitemid 38058430)
20. King GJ, Keeling SD, McCoy EA, Ward TH. Measuring dental drift and orthodontic tooth movement in response to various initial forces in adult rats. Am J Orthod Dentofacial Orthop 1991; 99:456-465.
21. Troost FJ, Steijns J, Saris WH, Brummer RJ. Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr 2001;131:2101-2104. (Pubitemid 32720637)
22. Trif M, Guillen C, Vaughan DM, et al. Liposomes as possible carriers for lactoferrin in the local treatment of inflammatory diseases. Exp Biol Med (Maywood) 2001;226:559-564. (Pubitemid 32524502)
23. Son Y, Lee JH, Kim NH, et al. Dilinoleoylphosphatidylcholine induces the expression of the anti-inflammatory heme oxygenase-1 in RAW264.7 macrophages. Biofactors 2010;36:210-215.
24. Ishikado A, Nishio Y, Yamane K, et al. Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells. Atherosclerosis 2009;205: 404-412.
25. Miyauchi M, Kitagawa S, Hiraoka M, et al. Immunolocalization of CXC chemokine and recruitment of polymorphonuclear leukocytes in the rat molar periodontal tissue after topical application of lipopolysaccharide. Histochem Cell Biol 2004;121: 291-297. (Pubitemid 38626427)
26. Roberts-Harry D, Sandy J. Orthodontics. Part 11: Orthodontic tooth movement. Br Dent J 2004;196: 391-394, quiz 426. (Pubitemid 38535208)
27. Matsuzaki H, Kobayashi H, Yagyu T, et al. Bikunin inhibits lipopolysaccharide-induced tumor necrosis factor alpha induction in macrophages. Clin Diagn Lab Immunol 2004;11:1140-1147. (Pubitemid 39540857)
28. Miyauchi M, Sato S, Kitagawa S, et al. Cytokine expression in rat molar gingival periodontal tissues after topical application of lipopolysaccharide. Histochem Cell Biol 2001;116:57-62. (Pubitemid 32695818)
29. Sanuki R, Shionome C, Kuwabara A, et al. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells. Connect Tissue Res 2010;51:150-158.
30. Grieve WG 3rd, Johnson GK, Moore RN, Reinhardt RA, DuBois LM. Prostaglandin E (PGE) and interleukin-1 beta (IL-1 beta) levels in gingival crevicular fluid during human orthodontic tooth movement. Am J Orthod Dentofacial Orthop 1994;105:369-374.
31. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M. Orthodontic tooth movement and de novo synthesis of proinflammatory cytokines. Am J Orthod Dentofacial Orthop 2001;119:307-312. (Pubitemid 33601203)